Personalizing cardiovascular disease prevention among breast cancer survivors

Current Opinion in Cardiology
Abhishek SinglaAditya Bardia

Abstract

With the advancement of breast cancer therapies, most women diagnosed with breast cancer in the United States are now expected to survive their disease, and management of competing comorbidities, particularly cardiovascular disease (CVD), is crucial. Recent studies have suggested that CVD is the most common cause of death for women diagnosed with ductal carcinoma in situ or stage I disease and for women aged more than 80 years with stage II disease. Various breast cancer therapies, including targeted therapies, can accentuate CVD risk; referrals for cardiology opinion are not uncommon at the time at which treatment options are under consideration. The use of less cardiotoxic alternatives, such as liposomal doxorubicin, and intensity-modulated radiation therapy should be considered when appropriate. Doppler myocardial imaging and cardiac MRI might allow early recognition of cardiotoxicity. It is important to weigh both the risk of CVD and that of breast cancer recurrence in a breast cancer survivor. Certain interventions for the primary prevention of CVD, including diet, physical activity, smoking cessation and aspirin, can reduce breast cancer risk as well. The management of CVD risk factors is of increasing importance in the m...Continue Reading

References

Nov 1, 1979·Annals of Internal Medicine·D D Von HoffF M Muggia
Mar 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J CuzickH Host
Mar 31, 1999·International Journal of Radiation Oncology, Biology, Physics·L F PaszatE Holowaty
May 30, 2001·European Journal of Heart Failure·S StewartJ J McMurray
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew SeidmanDeborah Keefe
Apr 9, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Coen W HurkmansBen J Mijnheer
Apr 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Lori J PierceBenedick A Fraass
May 2, 2002·Nature Medicine·Steven A CroneKuo-Fee Lee
Jun 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Cemil OzcelikAlistair N Garratt
Feb 19, 2003·Journal of Clinical Epidemiology·Tracie C CollinsCarol M Ashton
May 3, 2003·Journal of Clinical Epidemiology·Patricia BeckDavid Butler-Jones
Nov 1, 2003·Journal of Women's Health·Jane A CauleyDouglas C Bauer
Jan 30, 2004·Recent Progress in Hormone Research·Alejandra NegroKuo-Fen Lee
Nov 25, 2004·Technology in Cancer Research & Treatment·Susanta K HuiJames S Welsh
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy D MillerHope S Rugo
Mar 17, 2005·Journal of the National Cancer Institute·Sharon H GiordanoJames S Goodwin
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S Ewer, Scott M Lippman
May 26, 2005·JAMA : the Journal of the American Medical Association·Michelle D HolmesGraham A Colditz
Jul 15, 2005·Seminars in Oncology·Robert G ProsnitzLawrence B Marks
Sep 15, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Debra A PattSharon H Giordano
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark N Levine
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S EwerDaniel J Lenihan
Nov 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefanos BonovasNikolaos M Sitaras
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Krista M DaleC Michael White
Feb 1, 2006·International Journal of Radiation Oncology, Biology, Physics·Maartje J HooningFlora E van Leeuwen
Feb 24, 2006·The New England Journal of Medicine·Heikki JoensuuUNKNOWN FinHer Study Investigators
May 18, 2006·Journal of the National Cancer Institute·Jane A CauleyUNKNOWN Women's Health Initiative Research Group
Aug 15, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Stine S KorremanHåkan Nyström
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Valentina GuarneriFrancisco J Esteva
Oct 10, 2006·Preventive Medicine·Mark D MillerUNKNOWN California Environmental Protection Agency

❮ Previous
Next ❯

Citations

Nov 29, 2017·Oncology Research and Treatment·Jan SchmielauMonika Steimann
Aug 23, 2019·European Journal of Cancer Care·Jinyoung ShinYun-Mi Song
Mar 19, 2020·Journal of Racial and Ethnic Health Disparities·Michelle S WilliamsRoland J Jr Thorpe
Oct 8, 2019·European Journal of Preventive Cardiology·Flavio D'AscenziSergio Mondillo
Oct 16, 2019·European Journal of Preventive Cardiology·Flavio D'AscenziSergio Mondillo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
M A de KorteP J Perik
The New England Journal of Medicine
Heather L McArthur, Stephen Chia
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
R AbeleY Kenis
Hematology/oncology Clinics of North America
Gustavo IsmaelMartine Piccart-Gebhart
© 2022 Meta ULC. All rights reserved